Track GIP in Peptimes™
GIP (glucose-dependent insulinotropic polypeptide, also called gastric inhibitory polypeptide) is a gut hormone of 42 amino acids. FDA's substance registry lists it as gastric inhibitory polypeptide (1-42). (Source: FDA's substance registry (GSRS).)
Is GIP FDA-approved?
No. GIP, the body's own hormone, isn't an FDA-approved drug: Drugs@FDA lists no application with it as an active ingredient.
GIP
Also: glucose-dependent insulinotropic polypeptide, gastric inhibitory polypeptide, GIP(1-42)
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- SubcutaneousOther
- Updated
- 1 Nov 2026
US regulatory status
What studies have looked at
Each point says who or what was studied and what the study reported, with its source and the date we checked it. These are findings from the sources cited, not advice or a promise of any result.
- Review of studies
A 2018 review describes GIP and GLP-1 as the incretin hormones. In type 2 diabetes the incretin effect is reduced, largely because GIP works much less well on the pancreas; GIP also acts on fat cells, bone and the cardiovascular system.
Source: PMID 29364588, checked 1 Nov 2026
How to track it in Peptimes
Add GIP in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Routes: subcutaneous or Other. Choose the one that matches each dose.
- Logging: the amount you took, the route and how you feel.
- Injection sites: subcutaneous doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Doses logged as Other skip this step.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell GIP or any other compound.
More sources
- FDA, Global Substance Registration System, Gastric inhibitory polypeptide, checked 1 Nov 2026: its sequence of 42 amino acids and the name glucose-dependent insulinotropic polypeptide.
- FDA, Drugs@FDA, searched 1 Nov 2026: no application lists GIP as an active ingredient.